| |
|
|
| Name: |
SUPERSTRING CAPITAL MANAGEMENT LP |
| City: |
NEW YORK |
| State: |
NY |
| Zip: |
10022 |
| |
|
|
| Achive
data |
| View
Filing Period: |
|
|
|
|
|
|
 |
Download |
|
|
| |
| |
|
Free Registration Required For Full Results
|
|
|
| Holdings
Found :
30 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
 |
Ticker |
Company Name |
Position
Rank |
New/Closed
Postion |
Last
Close |
Value |
Shares Held |
% of
Portfolio |
Value
Change |
Change In
Shares Held |
% of Company |
Industry |
|
IMGN |
Immunogen Inc |
1 |
- |
$31.23 |
$17,733,000 |
598,072 |
12.66% |
0 |
0 |
0.271 |
Drug Manufacturers - ... |
|
|
CYTK |
Cytokinetics Inc |
2 |
- |
$65.34 |
$14,828,000 |
177,603 |
10.58% |
0 |
0 |
0.157 |
Biotechnology |
|
|
ETNB |
89bio, Inc. |
3 |
- |
$8.26 |
$11,410,000 |
1,021,477 |
8.14% |
0 |
0 |
1.371 |
N/A |
|
|
IONS |
Ionis Pharmaceuticals Inc |
4 |
- |
$41.59 |
$9,593,000 |
189,618 |
6.85% |
0 |
0 |
0.136 |
Drug Manufacturers - ... |
|
|
IDYA |
Ideaya Biosciences, Inc. |
5 |
- |
$0.00 |
$8,941,000 |
251,295 |
6.38% |
0 |
0 |
0.522 |
N/A |
|
|
PTGX |
Protagonist Therapeutics, Inc |
6 |
- |
$25.15 |
$8,694,000 |
379,143 |
6.21% |
0 |
0 |
0.674 |
N/A |
|
|
IMVT |
Immunovant Inc |
7 |
- |
$0.00 |
$8,577,000 |
203,592 |
6.12% |
0 |
0 |
0.234 |
N/A |
|
|
BBIO |
Bridgebio Pharma, Inc. |
8 |
- |
$24.88 |
$8,329,000 |
206,326 |
5.94% |
0 |
0 |
0.13 |
N/A |
|
|
DAWN |
Day One Biopharmaceuticals,... |
9 |
- |
$0.00 |
$5,543,000 |
379,626 |
3.96% |
0 |
0 |
0.613 |
N/A |
|
|
MRNS |
Marinus Pharmaceuticals Inc |
10 |
- |
$1.41 |
$5,027,000 |
462,444 |
3.59% |
0 |
0 |
0.932 |
N/A |
|
|
NBIX |
Neurocrine Biosciences Inc |
11 |
- |
$135.99 |
$3,867,000 |
29,346 |
2.76% |
0 |
0 |
0.031 |
Biotechnology |
|
|
URGN |
Urogen Pharma Ltd. |
12 |
- |
$14.15 |
$3,831,000 |
255,430 |
2.73% |
0 |
0 |
1.156 |
N/A |
|
|
SVRA |
Savara Inc |
13 |
- |
$4.41 |
$3,827,000 |
814,266 |
2.73% |
0 |
0 |
0.715 |
Biotechnology |
|
|
ROIV |
Roivant Sciences Ltd. |
14 |
- |
$11.03 |
$3,663,000 |
326,161 |
2.61% |
0 |
0 |
0.047 |
N/A |
|
|
LNTH |
Lantheus Holdings, Inc. |
15 |
- |
$65.56 |
$3,404,000 |
54,896 |
2.43% |
0 |
0 |
0.076 |
N/A |
|
|
FATE |
Fate Therapeutics Inc |
16 |
- |
$3.80 |
$3,171,000 |
847,823 |
2.26% |
0 |
0 |
0.715 |
Biotechnology |
|
|
KROS |
Keros Therapeutics, Inc. |
17 |
- |
$0.00 |
$2,968,000 |
74,649 |
2.12% |
0 |
0 |
0.22 |
N/A |
|
|
SLRN |
Acelyrin, Inc. |
18 |
- |
$4.24 |
$2,663,000 |
356,924 |
1.9% |
0 |
0 |
0.367 |
N/A |
|
|
VRNA |
Verona Pharma Plc |
19 |
- |
$0.00 |
$2,466,000 |
124,040 |
1.76% |
0 |
0 |
0.169 |
N/A |
|
|
NKTX |
Nkarta, Inc. |
20 |
- |
$0.00 |
$2,293,000 |
347,381 |
1.64% |
0 |
0 |
0.714 |
N/A |
|
|
KRYS |
Krystal Biotech Inc |
21 |
- |
$156.88 |
$1,996,000 |
16,086 |
1.42% |
0 |
0 |
0.065 |
N/A |
|
|
QTRX |
Quanterix Corp |
22 |
- |
$15.56 |
$1,962,000 |
71,760 |
1.4% |
0 |
0 |
0.196 |
N/A |
|
|
AXSM |
Axsome Therapeutics, Inc. |
23 |
- |
$71.71 |
$1,288,000 |
16,179 |
0.92% |
0 |
0 |
0.043 |
N/A |
|
|
SY |
So Young International Inc |
24 |
- |
$1.26 |
$1,003,000 |
796,059 |
0.72% |
0 |
0 |
0.747 |
N/A |
|
|
IMTX |
Immatics N.V |
25 |
- |
$10.01 |
$834,000 |
79,213 |
0.6% |
0 |
0 |
0.126 |
N/A |
|
|
ALLO |
Allogene Therapeutics, Inc. |
26 |
- |
$0.00 |
$713,000 |
222,112 |
0.51% |
0 |
0 |
0.158 |
N/A |
|
|
INZY |
Inozyme Pharma, Inc. |
27 |
- |
$0.00 |
$528,000 |
123,944 |
0.38% |
0 |
0 |
0.201 |
N/A |
|
|
FUSN |
Fusion Pharmaceuticals Inc. |
28 |
- |
$21.42 |
$440,000 |
45,801 |
0.31% |
0 |
0 |
0.096 |
N/A |
|
|
SPRB |
Spruce Biosciences, Inc. |
29 |
- |
$0.00 |
$348,000 |
118,814 |
0.25% |
0 |
0 |
0.318 |
N/A |
|
|
YS |
Ys Biopharma Ord Shs |
30 |
- |
$0.00 |
$166,000 |
307,920 |
0.12% |
0 |
0 |
0.331 |
N/A |
|
